Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-04

Clinical Trial Update: Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism [Phase 4]

View source ↗

Summary

This Phase 4 trial compares alfacalcidol to calcitriol for efficacy and safety in treating secondary hyperparathyroidism in patients with end-stage renal diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfacalcidol (alfacalcidol)
  • Calcitriol (calcitriol)

Snippet

Sponsor: Mahidol University | Conditions: Secondary Hyperparathyroidism, End Stage Renal Disease | Phase 4 | Status: COMPLETED